APP depletion alters selective pre- and post-synaptic proteins by Martinsson, lsak et al.
Contents lists available at ScienceDirect
Molecular and Cellular Neuroscience
journal homepage: www.elsevier.com/locate/ymcne
APP depletion alters selective pre- and post-synaptic proteins
Isak Martinssona, Estibaliz Capetillo-Zarateb,d,e, Mathilde Faideaua, Katarina Willéna,
Noemi Esterasb, Susanne Frykmanc, Lars O. Tjernbergc, Gunnar K. Gourasa,b,⁎
a Experimental Dementia Research Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden
bDepartment of Neurology and Neuroscience, Weill Cornell Medical College, New York, NY, USA
c Karolinska Institute, Dept. of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Huddinge, Sweden
dAchucarro Basque Center for Neuroscience, CIBERNED and Departamento de Neurociencias, Universidad del País Vasco. Leioa, Spain
e IKERBASQUE, Basque Foundation for Science, Bilbao, Spain
A R T I C L E I N F O
Keywords:
Amyloid precursor protein
Amyloid
Synapse
Alzheimer's disease
AMPA receptors
A B S T R A C T
The normal role of Alzheimer's disease (AD)-linked amyloid precursor protein (APP) in the brain remains in-
completely understood. Previous studies have reported that lack of APP has detrimental eﬀects on spines and
electrophysiological parameters. APP has been described to be important in synaptic pruning during develop-
ment. The eﬀect of APP knockout on mature synapses is complicated by this role in development. We previously
reported on diﬀerential changes in synaptic proteins and receptors in APP mutant AD transgenic compared to
wild-type neurons, which revealed selective decreases in levels of pre- and post-synaptic proteins, including of
surface glutamate receptors. In the present study, we undertook a similar analysis of synaptic composition but
now in APP knockout compared to wild-type mouse neurons. Here we demonstrate alterations in levels of
selective pre- and post-synaptic proteins and receptors in APP knockout compared to wild-type mouse primary
neurons in culture and brains of mice in youth and adulthood. Remarkably, we demonstrate selective increases
in levels of synaptic proteins, such as GluA1, in neurons with APP knockout and with RNAi knockdown, which
tended to be opposite to the reductions seen in AD transgenic APP mutant compared to wild-type neurons. These
data reinforce that APP is important for the normal composition of synapses.
1. Introduction
Despite nearly three decades since the formulation of the amyloid
cascade hypothesis of Alzheimer's disease (AD) the normal role of the β-
amyloid precursor protein (APP) and its various metabolites remain
poorly understood. AD is increasingly viewed as a disease of synapses.
Loss of the pre-synaptic protein synaptophysin has long been known to
be a better brain correlate of cognitive decline in AD (Masliah et al.,
1989; Terry et al., 1991) than the hallmark neuropathological lesions
that characterize AD, amyloid plaques and neuroﬁbrillary tangles,
composed of β-amyloid (Aβ) and tau, respectively.
To study the role of APP, knockout mice were generated (Zheng
et al., 1995), which were found to be smaller than their wild-type lit-
termates, and it was subsequently reported that they had memory
deﬁcits (Seabrook et al., 1999; Senechal et al., 2008). Primary neurons
from APP knockout (APP KO) mice were reported to have reduced
dendritic arbors (Perez et al., 1997; Tyan et al., 2012) while some
studies noted increased outgrowth and branching of axons (Young-
Pearse et al., 2008; Billnitzer et al., 2013). Moreover, spine density was
described as decreased in APP KO compared to wild-type mouse brains
(Lee et al., 2010; Tyan et al., 2012), and in vitro knockdown of APP was
shown to reduce spine density in rat hippocampal neurons in culture
(Lee et al., 2010). Seemingly contrary to these ﬁndings, it was reported
that cultured hippocampal knockout neurons showed increased sy-
naptophysin puncta and longer dendrites compared to their wild-type
counterparts (Priller et al., 2006); a subsequent study by the same
group further reported increased spine density in cortical layers 3 and 5
of 4–6months old APP KO mouse brains (Bittner et al., 2009), a dis-
crepancy reviewed by Jung & Herms (Jung and Herms, 2012).
We previously reported on diﬀerential alterations in synaptic com-
position in cultured neurons from Tg2576 AD transgenic compared to
wild-type mice (Almeida et al., 2005), where decreased levels parti-
cularly in GluA1 and PSD-95 were noted in the AD transgenic neurons.
Using a similar approach, we set out to investigate synaptic proteins in
cultured neurons and brains from APP KO mice. Since APP has been
reported to have important roles in neural development (Young-Pearse
et al., 2007; Nicolas and Hassan, 2014), we further silenced APP in
wild-type mouse neurons in culture following neurite outgrowth and
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synapse formation. Here we provide evidence for alterations in levels of
selective synaptic proteins, particularly in the AMPA receptor subunit
GluA1, with lack of APP, that tended to show increased levels compared
to the decreases in such synaptic proteins in AD transgenic neurons.
Taken together our results underscore important roles for APP in
normal synaptic composition.
2. Methods
2.1. Cloning
Viral vectors with short hairpin RNA (shRNA) targeting mouse APP
(Young-Pearse et al., 2007) were created by restriction digestion and
ligation into a modiﬁed pENTR plasmid(Campeau et al., 2009).
Gateway recombination was used to transfer the shRNA and scrambled
control RNA into a pLenti (Campeau et al., 2009) acceptor plasmid.
Lentiviral vectors were prepared by a viral vector core facility in Lund
University and titers were determined by immunoﬂuorescence. Trans-
duction of WT neurons was at 10 DIV and analysis at 14 DIV.
2.2. Antibodies
The following antibodies were employed: drebrin (Enzo, New York,
USA, AB_1533466; Abcam, UK, AB_2230303), GluA1 (Millipore,
Sweden, AB_2113602), NR1 (Upstate, New York, USA, AB_2112158),
post-synaptic density-95 (PSD-95) (Millipore, Sweden AB 2092365),
synaptophysin (Millipore, Sweden, AB_95187), 369 (C-terminal region
of APP (Buxbaum et al., 1990)), Alpha Tubulin (Sigma-Aldrich.
Sweden, AB_477593) and beta-actin (Sigma-Aldrich, Sweden,
AB_476743). We applied secondary antibodies conjugated to Alexa-
488, −546 and −647 (Thermo Fisher Scientiﬁc, Sweden) or HRP-
conjugated (Biotechna, UK).
2.3. Cell culture
Primary neuronal cultures, as well as harvesting of brain tissue,
were performed in accordance with the ethical guidelines and approved
by the Ethical committee for the use of laboratory animals at Lund
(M46-16) and Weill Cornell Medical College. Primary cortico-hippo-
campal neurons were harvested as described (Takahashi et al., 2004)
from C57Bl/6J (Jackson Labs, Maine, USA, JAX 000664) and APP KO
(Jackson Labs, Maine, USA, JAX 004133) mouse embryos at embryonic
day 16 (E16). Primary neuronal cultures were maintained in Neuro-
basal medium with added glutamine, B27 and penicillin/streptomycin
(Thermo Fisher Scientiﬁc, Sweden). Before plating the primary neu-
rons, glass coverslips were coated with poly-D-lysine molecular
weight > 300,000 (Sigma-Aldrich, Sweden) followed by rinses in au-
toclaved distilled water. Cell suspensions were plated in 10% FBS and
1% penicillin-streptomycin in Dulbecco's modiﬁed Eagle medium
(DMEM) (Thermo Fisher Scientiﬁc, Sweden); after 3–5 h media were
exchanged for complete Neurobasal medium. One embryo corresponds
to one set of cultures. No clear diﬀerences in cell density or viability
were noticed between WT and APP KO neurons at 12 and 19 DIV.
2.4. Viral vector transductions
Primary neuronal cultures were transduced at 10 DIV with lentiviral
vectors containing either the shRNA targeting APP or a scrambled
control at a multiplicity of infection of 5. Cells were maintained 4 days
post-transduction and at 14 DIV either ﬁxed for ﬂuorescence micro-
scopy or harvested for western blot analysis.
2.5. Mouse brain tissue
Equal amounts (25mg) of brain tissue snap-frozen in liquid nitrogen
derived from analogous cortical regions (frontal cortex) from brains of
male APP KO and wild-type mice both sacriﬁced (decapitation) at dif-
ferent ages (3 and 12months) were assayed for determination of sy-
naptic protein levels. Brain samples were lysed in radio-
immunoprecipitation assay (RIPA) buﬀer with protease inhibitor
cocktail (Roche Diagnostics, Sweden).
2.6. Western blot
Lysates were prepared using modiﬁed RIPA buﬀer containing
50mM Tris-HCl, pH 7.4, 1% NP-40, 0.25% sodium deoxycholate,
150mM NaCl, 1 mM EGTA, 1 tablet per 50ml complete protease in-
hibitor cocktail, and phosphatase inhibitor cocktail set II (Sigma-
Aldrich, Sweden). Protein concentrations were determined by the
Bradford technique (Bio-Rad, California, USA) or BCA protein assay kit
(Thermo Scientiﬁc, Sweden), and equal amounts of protein from each
sample were analyzed by NuPage 4–12% Bis-Tris SDS-PAGE (Thermo
Fisher Scientiﬁc, Sweden), Tris-Glycine SDS-PAGE or 10–20% Tricine
SDS- PAGE (Sigma-Aldrich, Sweden), followed by immunoblotting on
PVDF membranes (Sigma-Aldrich, Sweden). Membranes were im-
munoblotted with primary antibodies and intensities were quantiﬁed
using Scion Image software (NIH, RRID:SCR_008673) or Image Lab
5.2.1 (Bio-Rad, Sweden, RRID:SCR_014210). For full blots see
Supplementary Information.
2.7. Immunoﬂuorescence
After ﬁxation cells were rinsed in PBS at room temperature (RT).
Cells were then blocked in 0.1% Saponin (Sigma-Aldrich, Sweden), 1%
bovine serum albumin (BSA; Sigma-Aldrich, Sweden), and 2% normal-
goat serum (NGS; Thermo Fisher Scientiﬁc, Sweden) in PBS for 1 h at
RT. Primary antibodies were diluted in 2% NGS in PBS and incubated
overnight. Cells were then rinsed in PBS and incubated with the sec-
ondary antibodies in 2% NGS in PBS. Cells were rinsed in PBS and DAPI
(Sigma-Aldrich, Sweden) was used as counterstain in primary neuronal
cultures diluted at 1:2000. Cells were mounted on microscope slides
with Slowfade gold antifade reagent (Thermo Fisher Scientiﬁc,
Sweden). Fluorescence was analyzed with an inverted epiﬂuorescence
Olympus IX70 microscope, or a Leica SP5 or SP8 confocal microscope.
Quantiﬁcations of ﬂuorescence intensities and puncta densities were
performed by a blinded experimenter using the integrated morpho-
metric analysis feature in Metamorph (Molecular Devices, California,
USA, SCR 002368). Thresholds were set so that only puncta with in-
tensities (2×) brighter than that of the neurite shafts were quanti-
ﬁed;> 40 cells from 3 separate cultures were analyzed for each geno-
type. Analysis of spine density and length were performed manually by
a blinded experimenter using ImageJ (SCR 003070). In all analyses
blinding was performed before analysis by coding the names of the
image ﬁles. Sholl analysis was performed using an ImageJ plugin
(Ferreira et al., 2014), brieﬂy, thresholded bitmap images were mea-
sured from soma to furthest dendrite in the MAP2 channel. Then con-
centric circles of gradually increasing (30 μm) radii were calculated,
and the crossing points with the MAP2 channel automatically counted.
2.8. Experimental design and statistical analysis
All statistical analysis was performed using GraphPad Prism 7.2
(SCR 002798). Sample size is denoted as n=number of cells analyzed,
and N=number of animals. Prior to hypothesis testing data was tested
for normality with D'Agostino-Pearson omnibus K2 normality test for
determination of statistically appropriate test. Larger sample size data
sets were found to ﬁt normal distribution and therefore parametric tests
were used. For experiments where n < 8, data was assumed to ﬁt a
normal distribution without formal testing. All graphs are depicted as
mean ± 95% conﬁdence interval. For in between litter comparisons
samples were normalized to the wild-type mean of that litter. Statistical
comparisons were made using two-tailed unpaired t-tests for
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Fig. 1. APP knockout aﬀects the morphology of neuronal cultures. (a) Representative images of MAP2 and phalloidin labeling in WT and APP KO cultures at 19 DIV.
Scale bar= 50 μm. (b) Sholl analysis shows reduced dendritic branching in APP KO compared to WT neurons at 12 and 19 DIV. (c) Area under the curve for the Sholl
analysis curves. (d) Representative micrograph of phalloidin labeling for spines at 12 and 19 DIV. (e) Phalloidin puncta density is decreased in 19 DIV APP KO
compared to WT neurons; graph depicts mean ± 95% conﬁdence interval with N=3, n=30 neurons, scale bar= 3 μm.
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comparisons between two groups and paired t-tests for paired tests, and
one way ANOVA followed by Tukey's test when comparing multiple
groups. Statistical signiﬁcance was placed at p < 0.05 denoted *,
p < 0.005 denoted ** and p < 0.001 denoted *** unless otherwise
stated.
3. Results
3.1. Neuronal morphology is altered in APP knockout neurons
It has previously been shown that APP KO aﬀects neuronal mor-
phology and function (Perez et al., 1997; Tyan et al., 2012). Since there
are some discrepancies in the literature, we characterized our cortical
cultures of APP KO and wild-type (WT) neurons at 12 and 19 days in
vitro (DIV). Sholl analysis revealed that the APP KO neurons show re-
duced dendritic arbors compared to WT neurons both at 12 and 19 DIV
(Fig. 1a,b and c). To investigate spine density, we labeled the neurons
with phalloidin, which revealed reduced density of phalloidin puncta in
APP knockout compared to WT neurons at 19 DIV (Fig. 1d and e).
3.2. APP knockout leads to increased levels of GluA1
To investigate the eﬀects of APP KO on synaptic composition, APP
KO or WT primary neurons cultured for 12 or 19 DIV were analyzed by
western blot. We previously reported on decreases in selective synaptic
proteins, including pre-synaptic synaptophysin and the post-synaptic
AMPA receptor subunit GluA1 and PSD-95 in neurons of Tg2576 AD
transgenic mice overexpressing the Swedish mutation of APP, com-
pared to WT mice (Almeida et al., 2005). Remarkably, APP KO com-
pared to WT neurons at 12 DIV showed a threefold increase in levels of
GluA1 (322 ± 66% increase; p= 0.0025; n=8; Fig. 2), while there
were only non-signiﬁcant trends for increases in the pre-synaptic pro-
tein synaptophysin and the post-synaptic protein PSD-95, and decreases
in the NR1 subunit of the NMDA receptor. At 19 DIV there was a 1.5
fold increase in levels of PSD-95 (155% ± 14.9%, p=0.013; n=14)
and a 1.6 fold increase in levels of synaptophysin (159% ± 15.7%,
p=0.014), as well as a non-signiﬁcant change, albeit a trend for a 1.7
fold increase, in levels of GluA1 (178.7% ± 26.8%, p=0.064; n=14)
in APP KO compared to WT neurons (Fig. 2).
To further examine the eﬀects of APP knockout on synapse com-
position, the relative immuno-ﬂuorescence of select synaptic proteins
Fig. 2. Levels of selective pre- and post-synaptic proteins in APP KO compared to wild-type neurons in culture by western blot. (a) Representative Western blot of
select synaptic proteins in 12 DIV WT and KO cultures. (b) Quantiﬁcations of (a), normalized to beta-actin. There was a signiﬁcant increase in levels of the post-
synaptic AMPA receptor subunit GluA1 (322 ± 66% increase, p= 0.0025, WT n=8, KO n=8) at 12 DIV. (c) Representative Western blot of select synaptic
proteins in 19 DIV WT and KO cultures. (d) Quantiﬁcations of (c), normalized to beta-actin. Levels of post-synaptic PSD-95 (155% ± 14.9%, p=0.013, WT n=14,
KO n=14) and pre-synaptic synaptophysin (159% ± 15.7%, p= 0.014, WT n=14, KO n=14) were higher in the APP KO cultures at 19 DIV; graphs depict mean
and 95% conﬁdence intervals and n is indicated within each bar graph. Western blot scans are cropped; the bands analyzed were NR1 (130 kDa), synaptophysin
(38 kDa), GluA1 (106 kDa), drebrin (120 kDa) and PSD-95 (95 kDa).
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was measured in neurites of APP KO and WT neurons in culture. At 12
DIV, APP KO compared to WT neurons showed increased labeling of the
presynaptic protein synaptophysin (136.1% ± 13.3%, p=0.0018).
Further, there was increased labeling of the AMPA receptor subunit
GluA1 (135.8% ± 11.74%, p= 0.003) in the APP KO neurons at 12
DIV (Fig. 3a and b). No statistically signiﬁcant diﬀerences in the post-
synaptic proteins PSD-95 or the actin binding protein drebrin were
evident at 12 DIV, although there was a trend for increased PSD-95
labeling (p=0.06). At 19 DIV, levels of drebrin were now markedly
decreased by 40% ± 4% (p < 0.0001), while the other synaptic pro-
teins were all comparable to WT levels, although rather than the trend
for an increase at 12 DIV, there was now a trend for a decrease in PSD-
95 labeling in APP KO neurons, which however did not reach sig-
niﬁcance (p= 0.086; Fig. 3c and d).
To extend these ﬁndings from primary neurons in culture, we next
examined synaptic proteins in brain homogenates of frontal cortex of
APP KO compared to WT mice. At 3months of age, western blotting of
brain lysates showed an increase in levels of synaptophysin
(254 ± 14%; p < 0.0001) and GluA1 (187 ± 12%; p=0.0001) in
APP KO compared to WT mouse brains (Fig. 4a and b). However, at
12months of age there were no longer statistical diﬀerences in levels of
synaptophysin or GluA1, although there were now statistically sig-
niﬁcant increases in levels of PSD-95 (186 ± 19%; p=0.0010) but
decreases in levels of drebrin (47 ± 9%, p= 0.048) in APP KO brains
(Fig. 4a and c).
Thus, our results both in APP KO primary neurons and brains sup-
port statistically signiﬁcant increases in selective synaptic proteins. In
particular, post-synaptic GluA1, known to decline in AD, was increased
at early time points in culture (12 DIV) or early ages in brain (3months)
in APP KO mice, which however was not maintained at later time
points.
3.3. Levels of GluA1 are increased in neurons with lentiviral knockdown of
APP
Given the evidence for the involvement of APP in brain
Fig. 3. Levels of selective pre- and post-synaptic proteins in APP KO compared to wild-type neurons in culture by immunoﬂuorescence microscopy. Levels of pre-
synaptic synaptophysin, and post-synaptic GluA1, drebrin and PSD-95 were quantiﬁed in wild-type and APP KO primary neurons. (a–b) At 12 DIV immuno-
ﬂuorescence puncta of synaptophysin and GluA1 were increased in APP KO compared to wild-type neurons. (c–d) However, at 19 DIV synaptophysin and GluA1
puncta were similar in intensity to wild-type neurons, while drebrin puncta intensities were signiﬁcantly decreased (40% ± 4%, p < 0.001) in APP KO compared to
wild-type neurons; scale bar= 5 μm, graphs represent mean ± 95% conﬁdence intervals, n= 40 neurons.
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Fig. 4. Levels of selective pre- and post-synaptic proteins in
APP KO compared to wild-type mouse brains by western blot.
(a) Western blots of 3 and 12month-old WT and APP KO
brain. An overall similar pattern of changes in selective pre-
and post-synaptic proteins was seen in APP KO brains com-
pared to neurons in culture. (b) Quantiﬁcations of 3month-
old mouse brains normalized to beta-actin; levels of pre-sy-
naptic synaptophysin (254 ± 14%; p < 0.0001) and post-
synaptic GluA1 (187 ± 12%; p= 0.0001) were signiﬁcantly
higher in APP KO (n=4) compared to wild-type (n= 3)
mouse brains at 3months of age. (c) Quantiﬁcations of
12month-old mouse brains normalized to beta-actin. While
GluA1 and synaptophysin were not signiﬁcantly altered at
this age, there were increased levels of post-synaptic PSD-95
(186 ± 19%; p= 0.0010) and decreased levels of post-sy-
naptic drebrin (47 ± 9%, p=0.048) in 12month-old APP
KO mouse brains. Western blot scans are cropped; dotted line
in (a) represents cut out molecular weight marker.
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development, we next used RNAi to knock down APP in cultured wild-
type neurons in order to investigate the role of APP after the formation
of synapses. Typically a few days is needed for eﬀective lentiviral RNAi
knockdown in primary neurons, and to avoid too early knockdown, in
which case synapse development would be aﬀected, or too late
knockdown, since transduction can be more toxic to more aged neurons
in culture, we chose transduction at 10 DIV and analysis at 14 DIV. We
veriﬁed the knockdown of APP using Western blot with a C-terminal
APP antibody. Importantly there was no eﬀect on APP levels with the
scrambled control compared to non-transduced controls (Fig. 5a).
APP RNAi knockdown compared to the scrambled control RNAi at
10 DIV caused a signiﬁcant increase in the levels of GluA1
(142% ± 22.43%, p=0.0082) in cultured neurons when analyzed at
14 DIV by western blot (Fig. 5a and b). There was only a trend for
increases in PSD-95 with APP knockdown (140% ± 23.9% p=0.067),
and levels of the pre-synaptic protein synaptophysin remained un-
changed. Moreover, immunoﬂuorescence analysis of dendritic seg-
ments also showed an increase in levels of GluA1 (121% ± 7.8%;
p=0.023), but not in levels of PSD-95 or drebrin (Fig. 5c and d).
Lastly, we investigated whether spine density was altered with APP
knockdown in wild-type neurons. However, we did not detect any
signiﬁcant diﬀerences in spine density or length between the APP
knockdown and control neurons (Fig. 5e and f). Thus, knockdown of
APP in wild-type mouse neurons when initiated at 10 DIV and analyzed
at 14 DIV replicated the elevation in GluA1 seen in APP KO neurons,
but not the alterations in spine density.
4. Discussion
Numerous lines of evidence support that Aβ can have detrimental
eﬀects on synapses. However, the precise mechanism(s) of APP/Aβ's
involvement in AD remain to be determined. The following provide
support for synapses as being early and critical sites of damage in AD: 1.
APP is transported down axons and dendrites, and β- and γ–secretases
localize to synapses (Koo et al., 1990; Tampellini et al., 2009; DeBoer
et al., 2014; Lundgren et al., 2015; Schedin-Weiss et al., 2016); 2. Aβ is
preferentially generated, secreted and degraded upon increased sy-
naptic activity (Kamenetz et al., 2003; Cirrito et al., 2005; Tampellini
et al., 2009); 3. APP mRNA is locally translated at synapses (Westmark
and Malter, 2007); 4. Aβ accumulates and aggregates in synapses early
in AD (Takahashi et al., 2002; Takahashi et al., 2004); 5. Extracellular
Aβ binds to synapses (Lacor et al., 2004; Willen et al., 2017); 6. Aβ
accumulation in synaptosomes correlates with dementia and can dif-
ferentiate cognitively normal controls with high AD pathology from
dementia cases (Bilousova et al., 2016); 7. APP has been shown to
function as a trans-synaptic adhesion molecule (Wang et al., 2009; Stahl
et al., 2014).
Here we provide evidence that APP and/or its proteolytic cleavage
products are important for normal synaptic composition. We are not
aware of a similar comparison of levels of selective pre- and post-sy-
naptic proteins in APP KO primary neurons and brain combined with
comparisons to APP knockdown. Overall the most consistent increase
was in levels of the post-synaptic AMPA receptor subunit GluA1, which
was increased in APP KO neurons and brain at early time points in
primary neurons and young mouse brains, as well as with APP knock-
down in wild-type neurons. Remarkably, GluA1 was also the most
consistently aﬀected in our prior analysis of selective pre- and post-
synaptic changes in AD transgenic compared to wild type mouse neu-
rons (Almeida et al., 2005), although in contrast to the absence of APP,
the AD mutation led to a decrease in levels of GluA1. GluA1 is parti-
cularly important for synaptic plasticity and learning and memory, and
future work should focus on the precise mechanism(s) whereby APP
and/or its cleavage products aﬀect levels of this important post-sy-
naptic AMPA receptor subunit.
Our analysis was not always consistent when it came to changes in
some synaptic proteins in neurons with time in culture (12 versus 19
DIV) and compared to or between younger and older mouse brains (3
versus 12months), or with APP knockdown compared to APP knockout.
Moreover, ﬁndings on Western blot and immunoﬂuorescence did not
always overlap. It is important to note that Western blot assays total
levels of a selective protein, while immunoﬂuorescence of neurite
segments provides more localized information on levels in neurites. The
elevated levels on Western blot with unchanged or even reduced levels
of a synaptic protein by immunoﬂuorescence could, for example, reﬂect
reduced axonal or dendritic transport to synapses and thus accumula-
tion in neuron soma in APP KO compared to WT neurons.
Summarizing our results (see Fig. 6), we demonstrate that 1. APP
knockout alters the morphology (dendritic branching and spines) of
primary cortical neurons; 2. AMPA receptor subunit GluA1 is increased
in cultured neurons at 12 DIV and brains of 3months old APP KO mice;
3. Increased levels of GluA1 also with shRNA knockdown of APP sup-
ports an important role of APP in the composition of synapses rather
than eﬀects in APP KO mice being solely due to the role of APP in
development, although we cannot fully exclude an eﬀect on continued
maturation between 10 DIV (RNAi transduction) and 14 DIV (analysis).
4. Lack of APP alters post-synaptic proteins in mature cultures and adult
mice, at 19 DIV neurons and 12month-old mice, respectively, as shown
by increases in PSD-95 and decreases in drebrin.
Decreased phalloidin puncta and levels of drebrin were detected in
APP KO compared to wild-type neurons at 19 DIV despite an increase in
levels of the post-synaptic protein PSD-95. This reduction in phalloidin
puncta indicates a reduction in spine density in 19 DIV APP KO neu-
rons, an observation that ﬁts with previous reports on altered neuronal
morphology in APP KO neurons (Tyan et al., 2012; Weyer et al., 2014).
Further, since the phalloidin puncta density is not decreased sig-
niﬁcantly at 12 DIV in the knockout compared to WT, but the 19 DIV
WT neurons show a higher spine density than 12 DIV WT neurons, this
could reﬂect decreased formation and/or increased removal of spines in
APP KO neurons between 12 and 19 DIV. In fact, reduced spine turn-
over was shown in older APP KO mice, where environmental enrich-
ment failed to increase spine density compared to wild-type mice (Zou
et al., 2016). Neurons targeted by the APP shRNA vector, also showed
PSD-95 increases, however, without a change in spine density. It is
possible that changes in spine density might require more time than the
APP knockdown used here, with shRNA transduction at 10 DIV and
analysis at 14 DIV. Alternatively, PSD-95 increases have not been
shown to increase spines (Cane et al., 2014), while drebrin is more
closely correlated with spines (Koganezawa et al., 2017), and drebrin
was decreased in the APP KO neurons at 19 DIV but not with APP
knockdown (Fig. 6).
We detected increased levels of pre-synaptic synaptophysin at
3months in the APP KO mice; this ﬁnding, together with the increased
Fig. 5. Levels of selected pre- and post-synaptic proteins with shRNA mediated knockdown of APP. (a) Levels of synaptic proteins were determined by western blot
(normalized to tubulin) for 14 DIV cultures of WT neurons that were transduced with a lentiviral vector carrying shRNA against APP at 10 DIV; APP knockdown was
veriﬁed by antibody 369 against the APP C-terminus on western blot (one- way ANOVA p < 0.001). (b) Levels of post-synaptic GluA1 (142% ± 22.43%,
p= 0.0082, paired t-test) and PSD-95 (140% ± 23.9% p=0.067, paired t-test, p= 0.0225, unpaired two-sample t-test) were increased with shAPP transduction;
n= 4. Each dot in the graphs depicts one independent experiment. (c) Representative dendritic segments after transduction with scrambled (shSCRB) or shAPP
lentiviral constructs. (d) Quantiﬁcations of immunoﬂuorescence analysis. Levels of GluA1 increased with shAPP knockdown of APP (121% ± 7.8%; p=0.023);
scale bar= 3 μm, graphs show mean ± 95% conﬁdence interval, n= 40 neurons. (e) Confocal images of representative dendritic spines. (f) Quantiﬁcation of spine
density and length; no signiﬁcant diﬀerences between scrambled and shRNA APP knockdown was detected; graph depicts mean ± 95% conﬁdence interval, scale
bar= 3 μm. Western blot scans are cropped.
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Fig. 6. Schematic summary. Comparisons of morphologies of dendrites to WT neurons revealed decreased dendritic branching (12 and 19 DIV) and decreased spines
(19 DIV) in APP KO but not in APP KD neurons. Western blots revealed elevated GluA1 in APP KO (12 DIV) and APP KD compared to WT neurons, as well as elevated
synaptophysin and PSD-95 in APP KO compared to WT neurons at 19 DIV. Immunoﬂuorescence labeling revealed local increases of GluA1 in APP KO (12 DIV) and
APP KD, and in synaptophysin in APP KO (12 DIV) neurons. A local decrease of drebrin labeling was evident in APP KO neurons (19 DIV).
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synaptophysin immunoﬂuorescence labeling in cultured APP KO neu-
rons, ﬁts with earlier reports showing increased synaptophysin labeling
in hippocampi of p20 APP KO mice (Priller et al., 2006). The increased
synaptophysin with APP KO could result from increased axonal
branching and outgrowth during early development that has been de-
scribed (Perez et al., 1997; Young-Pearse et al., 2008; Billnitzer et al.,
2013). Moreover, APP was recently reported to act as a receptor for slit-
1, further implicating APP in early axon development (Wang et al.,
2017).
In conclusion, synapses appear to be key sites of APP biology and
function, and it will be important to provide a clearer molecular un-
derstanding of the precise role(s) of APP and its cleavage products at
synapses. Taken together, our results strengthen the important role of
APP in synaptic composition.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.mcn.2019.02.003.
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